BMRA
Biomerica, Inc.
Medical - Devices
Market Cap$7M
5Y Perf.-95.7%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
BMRA vs OSUR
Revenue, margins, valuation, and 5-year total return — side by side.
OSUR
OraSure Technologies, Inc.
Medical - Instruments & Supplies
Market Cap$220M
5Y Perf.-79.0%
BMRA vs OSUR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | BMRA | OSUR |
|---|---|---|
| Industry | Medical - Devices | Medical - Instruments & Supplies |
| Market Cap | $7M | $220M |
| Revenue (TTM) | $4M | $85M |
| Net Income (TTM) | $-4M | $-53M |
| Gross Margin | 5.6% | 38.8% |
| Operating Margin | -118.1% | -58.6% |
| Total Debt | $458K | $13M |
| Cash & Equiv. | $2M | $199K |
BMRA vs OSUR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
BMRA
OSUR
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Biomerica, Inc. (BMRA) | 100 | 4.3 | -95.7% |
| OraSure Technologie… (OSUR) | 100 | 21.0 | -79.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BMRA vs OSUR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: OSUR leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and recent price momentum and sentiment. Biomerica, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
BMRA
Biomerica, Inc.
The Income Pick
BMRA is the clearest fit if your priority is income & stability and growth exposure.
- beta 0.95
- Rev growth -1.9%, EPS growth -5.0%, 3Y rev CAGR -34.5%
- Lower volatility, beta 0.95, Low D/E 11.2%, current ratio 2.80x
Best for: income & stability and growth exposure
OSUR
OraSure Technologies, Inc.
The Long-Run Compounder
OSUR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- -54.1% 10Y total return vs BMRA's -81.9%
- -61.9% margin vs BMRA's -90.3%
- +17.7% vs BMRA's -35.8%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | BMRA | -1.9% revenue growth vs OSUR's -38.1% |
| Quality / Margins | OSUR | -61.9% margin vs BMRA's -90.3% |
| Stability / Safety | BMRA | Beta 0.95 vs OSUR's 1.43 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | OSUR | +17.7% vs BMRA's -35.8% |
| Efficiency (ROA) | OSUR | -12.8% ROA vs BMRA's -66.7%, ROIC -20.0% vs -143.5% |
BMRA vs OSUR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2021
FY 2025
BMRA vs OSUR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLOSURLAGGINGBMRA
BMRABiomerica, Inc.
0leads
OSUROraSure Technologies,…
4leads
6 Total Categories
CATEGORYLEADERvs BMRAMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
OSUR5/6
Valuation MetricsMultiples, price ratios, and targets
OSUR2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
OSUR5/8
Total Returns1Y, 3Y, 5Y total returns with dividends
OSUR6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
OSUR leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OSUR is the larger business by revenue, generating $85M annually — 19.1x BMRA's $4M. OSUR is the more profitable business, keeping -61.9% of every revenue dollar as net income compared to BMRA's -90.3%. On growth, BMRA holds the edge at -26.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | BMRABiomerica, Inc. | OSUROraSure Technolog… |
|---|---|---|
| RevenueTrailing 12 months | $4M | $85M |
| EBITDAEarnings before interest/tax | -$5M | -$43M |
| Net IncomeAfter-tax profit | -$4M | -$53M |
| Free Cash FlowCash after capex | -$3M | -$48M |
| Gross MarginGross profit ÷ Revenue | +5.6% | +38.8% |
| Operating MarginEBIT ÷ Revenue | -118.1% | -58.6% |
| Net MarginNet income ÷ Revenue | -90.3% | -61.9% |
| FCF MarginFCF ÷ Revenue | -65.7% | -56.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -26.0% | -99.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.1% | -52.4% |
OSUR leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
OSUR leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | BMRABiomerica, Inc. | OSUROraSure Technolog… |
|---|---|---|
| Market CapShares × price | $7M | $220M |
| Enterprise ValueMkt cap + debt − cash | $5M | $233M |
| Trailing P/EPrice ÷ TTM EPS | -1.03x | -3.26x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 1.23x | 1.91x |
| Price / BookPrice ÷ Book value/share | 1.24x | 0.66x |
| Price / FCFMarket cap ÷ FCF | — | — |
OSUR leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
OSUR leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
OSUR delivers a -15.1% return on equity — every $100 of shareholder capital generates $-15 in annual profit, vs $-91 for BMRA. OSUR carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to BMRA's 0.11x. On the Piotroski fundamental quality scale (0–9), BMRA scores 4/9 vs OSUR's 3/9, reflecting mixed financial health.
| Metric | BMRABiomerica, Inc. | OSUROraSure Technolog… |
|---|---|---|
| ROE (TTM)Return on equity | -90.8% | -15.1% |
| ROA (TTM)Return on assets | -66.7% | -12.8% |
| ROICReturn on invested capital | -143.5% | -20.0% |
| ROCEReturn on capital employed | -91.3% | -16.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.11x | 0.04x |
| Net DebtTotal debt minus cash | -$2M | $13M |
| Cash & Equiv.Liquid assets | $2M | $199,278 |
| Total DebtShort + long-term debt | $458,000 | $13M |
| Interest CoverageEBIT ÷ Interest expense | — | — |
OSUR leads this category, winning 5 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
OSUR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OSUR five years ago would be worth $3,145 today (with dividends reinvested), compared to $674 for BMRA. Over the past 12 months, OSUR leads with a +17.7% total return vs BMRA's -35.8%. The 3-year compound annual growth rate (CAGR) favors OSUR at -24.1% vs BMRA's -40.8% — a key indicator of consistent wealth creation.
| Metric | BMRABiomerica, Inc. | OSUROraSure Technolog… |
|---|---|---|
| YTD ReturnYear-to-date | -12.3% | +28.6% |
| 1-Year ReturnPast 12 months | -35.8% | +17.7% |
| 3-Year ReturnCumulative with dividends | -79.3% | -56.2% |
| 5-Year ReturnCumulative with dividends | -93.3% | -68.6% |
| 10-Year ReturnCumulative with dividends | -81.9% | -54.1% |
| CAGR (3Y)Annualised 3-year return | -40.8% | -24.1% |
OSUR leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — BMRA and OSUR each lead in 1 of 2 comparable metrics.
Risk & Volatility
BMRA is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than OSUR's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OSUR currently trades 80.1% from its 52-week high vs BMRA's 48.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | BMRABiomerica, Inc. | OSUROraSure Technolog… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 1.43x |
| 52-Week HighHighest price in past year | $4.60 | $3.82 |
| 52-Week LowLowest price in past year | $1.87 | $2.08 |
| % of 52W HighCurrent price vs 52-week peak | +48.3% | +80.1% |
| RSI (14)Momentum oscillator 0–100 | 54.0 | 56.3 |
| Avg Volume (50D)Average daily shares traded | 21K | 469K |
Evenly matched — BMRA and OSUR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | BMRABiomerica, Inc. | OSUROraSure Technolog… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $4.00 |
| # AnalystsCovering analysts | — | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +6.8% |
Insufficient data to determine a leader in this category.
Key Takeaway
OSUR leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
Best OverallOraSure Technologies, Inc. (OSUR)Leads 4 of 6 categories
Loading custom metrics...
BMRA vs OSUR: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is BMRA or OSUR a better buy right now?
For growth investors, Biomerica, Inc.
(BMRA) is the stronger pick with -1. 9% revenue growth year-over-year, versus -38. 1% for OraSure Technologies, Inc. (OSUR). Analysts rate OraSure Technologies, Inc. (OSUR) a "Hold" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BMRA or OSUR?
Over the past 5 years, OraSure Technologies, Inc.
(OSUR) delivered a total return of -68. 6%, compared to -93. 3% for Biomerica, Inc. (BMRA). Over 10 years, the gap is even starker: OSUR returned -54. 1% versus BMRA's -81. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BMRA or OSUR?
By beta (market sensitivity over 5 years), Biomerica, Inc.
(BMRA) is the lower-risk stock at 0. 95β versus OraSure Technologies, Inc. 's 1. 43β — meaning OSUR is approximately 51% more volatile than BMRA relative to the S&P 500. On balance sheet safety, OraSure Technologies, Inc. (OSUR) carries a lower debt/equity ratio of 4% versus 11% for Biomerica, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — BMRA or OSUR?
By revenue growth (latest reported year), Biomerica, Inc.
(BMRA) is pulling ahead at -1. 9% versus -38. 1% for OraSure Technologies, Inc. (OSUR). On earnings-per-share growth, the picture is similar: OraSure Technologies, Inc. grew EPS -261. 5% year-over-year, compared to -500. 0% for Biomerica, Inc.. Over a 3-year CAGR, OSUR leads at -33. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BMRA or OSUR?
OraSure Technologies, Inc.
(OSUR) is the more profitable company, earning -59. 8% net margin versus -93. 6% for Biomerica, Inc. — meaning it keeps -59. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OSUR leads at -59. 2% versus -96. 7% for BMRA. At the gross margin level — before operating expenses — OSUR leads at 41. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — BMRA or OSUR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is BMRA or OSUR better for a retirement portfolio?
For long-horizon retirement investors, Biomerica, Inc.
(BMRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95)). Both have compounded well over 10 years (BMRA: -81. 9%, OSUR: -54. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between BMRA and OSUR?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(BMRA: -26.0% · OSUR: -99.9%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.